Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.
about
Drug-resistant TB: deadly, costly and in need of a vaccineTuberculosis vaccines and prevention of infectionComputational and Empirical Studies Predict Mycobacterium tuberculosis-Specific T Cells as a Biomarker for Infection Outcome.Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilizationSafety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trialA small RNA encoded in the Rv2660c locus of Mycobacterium tuberculosis is induced during starvation and infectionOral bacillus Calmette-Guérin vaccine against tuberculosis: why not?Immunology studies in non-human primate models of tuberculosisNovel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety ConsiderationsEvaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial.A novel therapeutic strategy of lipidated promiscuous peptide against Mycobacterium tuberculosis by eliciting Th1 and Th17 immunity of hostHarnessing local and systemic immunity for vaccines against tuberculosis.Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine.Vaccines: An age-old problem.Reasons for optimism in the search for new vaccines for tuberculosis.Progress and challenges in TB vaccine development.Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to Mycobacterium tuberculosis.Age-related waning of immune responses to BCG in healthy children supports the need for a booster dose of BCG in TB endemic countriesRecent developments in tuberculosis vaccines
P2860
Q26765385-FEF02554-121C-4476-BEEE-EC3F4D75CC83Q26782022-855E78EC-C7A4-4673-9675-F9F5DCFCADF7Q27316676-8CA1A822-42F4-40B2-B479-49788F105698Q27321593-80F1E381-A3F8-48E0-B10A-AE5849CEDAA6Q29620144-F89EAF23-5896-4913-A6B4-ECC87ACDECF5Q31146213-9A596371-199A-46B6-9F41-D054DC5F572DQ34548500-BF1DE5AB-634D-4648-9DB5-852E1CD36E7DQ35116998-BC31433C-D447-4A4F-86B8-6FB46BD46695Q35826779-0737966C-2F33-461C-8CBF-A7758670EC2CQ35836969-6DDE0E79-377A-4593-B63F-681A49CA55F0Q36774253-BE29A9B4-6AF2-46C3-B302-C3AA8AC5C34BQ38164196-C1AA2D85-4296-4499-9434-8CB2AC249813Q40190981-591578B7-3232-444E-9554-DEA93A1B089CQ45101532-8664373B-FFB6-47F6-997A-DF4D59C33475Q47327109-05463752-B7C2-4247-ADA9-E82F344CBB66Q52641498-64C1DF12-EC8C-49E5-8B0A-0AA3CC0E4503Q52641618-E04B7C88-57C0-4329-8885-28A694A07375Q58549133-055B9F23-553A-4B21-89FF-5D93C8576097Q58834925-BB0F5298-3F80-4F2A-8F42-2995FD986B42
P2860
Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Lessons learnt from the first ...... uberculosis vaccine since BCG.
@ast
Lessons learnt from the first ...... uberculosis vaccine since BCG.
@en
type
label
Lessons learnt from the first ...... uberculosis vaccine since BCG.
@ast
Lessons learnt from the first ...... uberculosis vaccine since BCG.
@en
prefLabel
Lessons learnt from the first ...... uberculosis vaccine since BCG.
@ast
Lessons learnt from the first ...... uberculosis vaccine since BCG.
@en
P2093
P2860
P50
P1433
P1476
Lessons learnt from the first ...... uberculosis vaccine since BCG.
@en
P2093
Angelique K K Luabeya
Bernard Landry
Hassan Mahomed
J Bruce McClain
Jacqui Shea
Linda van der Merwe
Robert Walker
P2860
P304
P356
10.1016/J.TUBE.2013.01.003
P50
P577
2013-02-12T00:00:00Z